Bio-Connect
WB analysis of PANC1 cells using GTX46323 RHBDL2 antibody at 0.2-1microg/ml.
WB analysis of PANC1 cells using GTX46323 RHBDL2 antibody at 0.2-1microg/ml.
WB analysis of PANC1 cells using GTX46323 RHBDL2 antibody at 0.2-1microg/ml.

RHBDL2 antibody, N-term

GTX46323
GeneTex
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetRHBDL2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    RHBDL2 antibody, N-term
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 0.2-2.5 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5-1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID54933
  • Target name
    RHBDL2
  • Target description
    rhomboid like 2
  • Target synonyms
    rhomboid (veinlet, Drosophila)-like 2; rhomboid protease 2; rhomboid, veinlet-like 2; rhomboid-like protein 2; rhomboid-related protein 2; RRP2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9NX52
  • Protein Name
    Rhomboid-related protein 2
  • Scientific Description
    The protein encoded by this gene is a member of the rhomboid family of integral membrane proteins. This family contains proteins that are related to Drosophila rhomboid protein. Members of this family are found in both prokaryotes and eukaryotes and are thought to function as intramembrane serine proteases. The encoded protein is thought to release soluble growth factors by proteolytic cleavage of certain membrane-bound substrates, including ephrin B2 and ephrin B3. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2015]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Cancer-associated fibroblast infiltration in osteosarcoma: the discrepancy in subtypes pathways and immunosuppression.
    Read more